Altamira Therapeutics Provides Business Update and First Half 2022 Financial Results
Go back to Altamira Therapeutics Provides Business Update and First Half 2022 Financial Results| Cytogen Corp (NASDAQ: CYTO) | Delayed: 0.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $0.61 | |||
| Open | $0.30 | 52 Week Low | $0.61 | |||
| Day High | $0.30 | P/E | N/A | |||
| Day Low | $0.30 | EPS | $-0.79 | |||
| Volume | 7,307,514 | |||||
| Cytogen Corp (NASDAQ: CYTO) | Delayed: 0.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $0.61 | |||
| Open | $0.30 | 52 Week Low | $0.61 | |||
| Day High | $0.30 | P/E | N/A | |||
| Day Low | $0.30 | EPS | $-0.79 | |||
| Volume | 7,307,514 | |||||

